INTERNATIONAL STEM CELL CORPORATION

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2011–2013

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2013	—	2	1
2012	—	4	1
2011	—	4	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
ML STRATEGIES, LLC	—	10

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	7
SENATE	7
Natl Institutes of Health (NIH)	4
White House Office	2
Natl Economic Council (NEC)	1

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	10

Bills Explicitly Cited (1)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 3671112th Congress

Consolidated Appropriations Act, 2012

2011 · fourth_quarter · Firm: ML STRATEGIES, LLC

Open original LDA filing ↗

Cited source text and reported amounts

General issues relating to federal regulation of stem cell research. H.R.3671, Consolidated Appropriations Act, 2012, issues related to stem cell research.

Client expense: — · Firm income: $30,000

Matched citations: H.R.3671

Source: Senate LDA

INTERNATIONAL STEM CELL CORPORATION — Lobbying Disclosure | Poliscope